TrialJAMA ophthalmology2014

Evaluation of results 1 year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy.

Abdhish R Bhavsar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.